{"preliminary_commentary":{"by_channel":{"x_thread":5},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT07131514","nct_id":"NCT07131514","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct07131514. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab will be administrated per dose level in which the patients are assigned.","label":"HRS-4642+AG +Adebrelimab","type":"EXPERIMENTAL"}],"collaborators":["Jiangsu HengRui Medicine Co., Ltd."],"completion_date":{"date":"2027-12","type":"ESTIMATED"},"conditions":["Pancreatic Cancer"],"enrollment":{"count":30,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"HRS-4642+AG +Adebrelimab","otherNames":[],"type":"DRUG"}],"last_update":"2026-05-27","lead_sponsor":"Ruijin Hospital","official_title":"An Exploratory Clinical Study of HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","overall_status":"RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2027-06","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Adverse events (AEs)","timeFrame":"From the first drug administration to within 30 days for the last dose"},{"measure":"Objective Response Rate (ORR)","timeFrame":"Up to approximately 6 months"}],"references":[],"start_date":{"date":"2025-08-25","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer","url":"https://clinicaltrials.gov/study/NCT07131514"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct07131514"}